VALUE-BASED ADVANCED CLINICAL BENCHMARKING
    3.
    发明公开

    公开(公告)号:EP4109464A1

    公开(公告)日:2022-12-28

    申请号:EP21180742.5

    申请日:2021-06-22

    IPC分类号: G16H40/20

    摘要: A computer-implemented method, an apparatus and a computer program for analyzing data related to a plurality of healthcare delivery units. The method comprises collecting data from different data sources related to the plurality of healthcare delivery units; computing, based on the collected data, for individual patients associated with any one of the plurality of healthcare delivery units, an expected frequency of at least one type of health outcome for each of the individual patients; and generalizing the computed expected frequencies of the at least one type of health outcome for the individual patients into one or more individual-level impact metrics associated with one or more risk factors for the at least one type of health outcome, wherein the one or more risk factors comprise one or more modifiable risk factors and one or more un-modifiable risk factors.

    BLUTBEHANDLUNGSVORRICHTUNG
    4.
    发明公开

    公开(公告)号:EP3334479A1

    公开(公告)日:2018-06-20

    申请号:EP16757558.8

    申请日:2016-08-10

    IPC分类号: A61M1/36 A61M1/16 A61M1/34

    摘要: The invention relates to a blood treatment device comprising an extracorporeal circuit, a dialysate circuit, and a dialysis machine which has a blood-side chamber and a dialysate-side chamber which is separated from the blood-side chamber by a membrane. The invention is characterized in that the blood-side chamber is fluidically connected to the extracorporeal circuit, and the dialysate-side chamber is fluidically connected to the dialysate-circuit. The blood treatment device also comprises a preparation unit for the on-line production of a solution. The invention is characterized in that the blood treatment device has first means for carrying out a priming mode and second means for carrying out an initial treatment mode. The first means is designed to actuate the preparation unit such that a flushing solution with a pH value of ≥ 7.3 and preferably ≥ 7.4 is produced, and the extracorporeal circuit is filled with the flushing solution. The second means is designed to actuate the preparation unit such that dialysate with a pH value of ≥ 7.3 and preferably ≥ 7.4 is produced and the dialysate circuit is filled with the dialysate. The blood treatment device also has a control or regulating unit which operates the first means prior to the second means.